Funding Fuels National Sales Expansion and Launch of New Ortho EDG Sizes to Broaden Surgical Applications and Meet Rising ...

Amid global expansion, Black Book advances its trusted, independent research model-implementing AI-powered KPIs, longitudinal client tracking, and purpose-built surveys tailored to virtual care, value ...

AGM/EGM/DividendDrägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves dividend increase – Inclusion of the preferred shares in the TecDAX 09.05.2025 / 15:26 CET/CESTThe issuer is ...

NextCell CSO Lindsay Davies Honoured with Multiple New Leadership Roles Within European Cell Therapy Community Davies' expertise critical to translating NextCell’s lead MSC product, ProTrans, through ...

UK Healthcare M&A remains robust throughout Q1 as deals continue to flow in 2025Pharma and life sciences and healthcare IT saw a notable uptick in volumes in March. The UK Healthcare M&A sector has ...

Full Year 2025 Trading UpdateKromek to deliver revenue and profits ahead of market expectations Kromek Group plc (AIM: KMK), a leading developer of radiation and bio-detection technology ...

OTUS Launches in the U.S. as a Smart Vision Training Solution for Modern Vision Therapy Centers.Built for professionals, OTUS enables more efficient and precise accommodative training through ...

SHENZHEN, CHINA AND LONDON, GB / ACCESS Newswire / May 9, 2025 / Lancens Technology, a leading developer of IoT connectivity solutions, today announced its selection as the core technology provider ...

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018 ...

Today, Gubra releases its results for the first quarter of 2025. The key development in the quarter was the out-licensing agreement to AbbVie for our anti-obesity asset GUBamy (Amylin). A landmark ...

The global sports drug testing market is set for substantial expansion, with projections indicating a rise from USD 13.4 billion in 2022 to an impressive USD 20.6 billion by 2032. This represents a ...

The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...